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Abstract
Objective: Human jawbones consist mainly of hydroxylapatite. The aim of this study was to assess the structure of solid 
calcium phosphate compounds of the jaw bone (JB) in cases of normal and osteoporotic JBs. 
Design: The X-ray diffraction technique was used to analyze the structure of samples of cadavers’ jawbones. The experimental 
JB samples were taken from an osteoporotic and atrophic jawbone, and control samples were from normal and nonosteoporotic 
bone samples. 
Results: Hydroxylapatite was the only phase in control bone samples. In experimental bone samples, the above-mentioned 
phase was registered, as well as monetite and brushite. 
Conclusion: The obtained data indicated that the changes of crystalographic forms of calcium phosphate in the physiologic 
system were balanced according to the possibility of change in the inorganic chemical system.
Keywords: X-ray diffraction; mineralized tissues; bone; jaw.
Introduction
Calcium orthophosphates are important compounds 
in biological systems because calcium is the main mineral 
constituent of bones [1,2]. These compounds materialize in 
various forms (Table 1) [1], but for jawbones, which were 
investigated in this study, the most important compounds of 
calcium are hydroxylapatite (HAp) Ca10(PO4)6(OH)2  (in some 
publications [2,5], the formula Ca5(PO4)3(OH) has been cited), 
monetite (monoclinic or hexagonal) (M) CaHPO4 (monoclinic)  
and brushite (B) CaHPO4
.2H2O (triclinic) [1]. The existence 
of amorphous phases  [3,4] of calcium phosphate was also 
registered. The solubility products [1] at 37ºC are L=9.2 .10−7 
for monetite, L=1.87 . 10−7 for brushite, and L=5.5 . 10−118  for 
hydroxyapatite. However, in another report [5], the value of 
L=2.27 . 10−58 at 37ºC for hydroxylapatite is different. Brushite 
is formed by mixing the solutions of CaCl2 (0.01–0.08 mol/l) 
and NaHPO4 
. H2O (0.005–0.08 mol/l), at pH<7.1, at 25ºC. 
However,  at  pH=7.1  and  higher,  amorphous  sediment  of 
calcium phosphate is formed, in which the ratio of Ca:P=1.47. 
In  the  mixture  of  the  calcium  hydroxide  suspension  and 
orthophosphoric  acid  solution,  five  consecutive  levels  of 
the reaction were identified [6], in which previously formed 
hydroxylapatite was transformed to brushite with a solubility 
product in the temperature function [6] of L=e(8403/T +41.8−0.97 T). 
At 37ºC and pH=6, the rate of brushite formation is more than 
1000 times higher than the rate of formation of hydroxylapatite. 
In water solution with an initial pH=10.8, at a temperature 
of 39ºC, after a prolonged period of hydrolysis, brushite is 
transformed into hydroxylapatite, which is deficient in calcium 
[7], but after more prolonged hydrolysis, it is transformed into 
hydroxylapatite.  The  addition  of  Ca++ ions accelerates the 
formation of HAp. Therefore, amorphous calcium phosphate 
has the role in the processes of formation of crystal calcium 
phosphate  [8].  The  synthetic  hydroxyapatite  [9],  which  is 
used in production of artificial teeth and artificial jaws, is of a 
different structure compared to natural hydroxylapatite, mainly 
because  of  different  crystallinity,  which  has  been  changed 
by mechanical crushing and mixing of particles, and during 
temperature processing. Thus, many scientific explanations are 
focused on characterizing the group of chemical compounds, 
consisting  mainly  of  calcium  phosphates,  that  are  used  as 
basic structures in the fabrication of orthopaedic and dental 
cements [9]. The influence of modality in the fabrication of 
hydroxylapatite was assessed, as well as the mode of purifying 
it with a strictly defined relationship of granulations of wet 
*Corresponding author:    Srđan  D.  Poštić,  PhD.    Clinic 
of Dental Prosthetic, School of Dental Medicine, University of 
Belgrade.E-mail: srdjan.postic@stomf.bg.ac.rs
MODERN MEDICAL EQUIPMENT110                                                  S. D. Poštić / International Journal of BioMedicine 4(2) (2014) 109-113
and dry particles, for compression of the final product [10,11]. 
Certain studies support the selection of Ca5(PO4)3(OH).
Detection of calcium and phosphorus contents in the JB 
at the location where natural teeth are connected to the bones 
of osteoporotic people showed decreased levels of minerals in 
the environments assessed [12].
In the solutions, which simulate body fluid (artificial 
saliva,  artificial  serum  etc),  the  precipitation  of  calcium 
phosphate  was  investigated  theoretically  [13]  as  well 
experimentally [14-16] by dissolving these compounds [17-
19], and the synthesis of different forms of calcium phosphates 
and  their  transformations  [20-22]  was  used  to  fabricate 
bioceramics and for various usages of bioceramics.
Bone consists of different solid chemical compounds. 
The content as well as the structure of the solid phase should 
influence  macro-appearance  and  bone  strength.  However, 
some solid compounds in bone could be gradually transformed 
to other compounds. So far, there are not many reports in the 
literature  about  these  assumptions  [23-25].  Stoichiometric 
hydroxylapatite (CaO/P2O5), hydroxylapatite (HAp), monetite, 
and brushite compounds have been reported in the literature, 
as the specific forms present in the bone’s solid phase [1-4,8, 
11-12]. 
The aim of this study was to assess the structure of solid 
calcium phosphate compounds of the jawbone in cases of 
normal and osteoporotic JBs. 
Material and Methods
Samples
Bone samples were carefully extracted from the lower 
jawbones of cadavers. Written consent and approval for using 
cadaveric materials was obtained from the responsible medical 
institution, the Institute for Forensic Medicine in Belgrade.
The samples were similar in dimensions. Two types of 
bone samples were provided: 1) experimental samples (E) with 
changed atrophic and osteoporotic structures and 2) control 
samples (C) taken from the normal bone. The existence of 
osteoporosis was proposed. Two sample’s probes of each sort 
were used (E1 and E2, C1 and C2). Samples E1 and C1 were 
obtained from complete bone samples, but samples E2 and C2 
were obtained from the exterior layer of the corresponding 
bone.  Samples  were  isolated,  cleaned,  and  degreased  in 
acetone with the intention of preparing them for examination 
[13,14,26]. After drying and storage in vacuum conditions, 
samples were mechanically dusted in agate mortar.
X-ray diffraction analysis
X-ray diffraction analysis was applied to detect the 
phases and compounds of samples of jawbones. A powder 
mixture  was  placed  in  a  diffractometer  (Crystalloflex 
diffractometer D-500, Siemens). An electrical voltage of 35kV 
with 20 mA was used for this experiment.
Results
In  Figures  1  and  2,  X-ray  diffractograms  of  E1 and 
E2  samples  are  presented. The  diffractogram  of  sample  C1 
is shown in Figure 1. It is the same as the diffractogram of 
sample C2. 
In  Table  2,  the  band  positions  (2θ,  degree)  in  the 
diffractograms  of  samples  and  relative  intensities  (i/s)  are 
given.  In  Figures  1–3  are  given  the  Miller  indexes  and 
Table 1.  
Calcium Orthophosphate Minerals1
Compound     Ca/P  
molar 
ratio         
Formula                             Space  group -logK 
(370) *                           
Brushite (DCPD)        1 . 0 0                    CaHPO4
 .
 2 H2O                     monoclinic, Ia            6.73
Monetite(DCPA)                1 . 0 0                                                           CaHPO4 triclinic P1                     6.04
Octacalcium-                    
phosphate (OCP  
1 . 3 3                       
 
Ca8(HPO4).
2(PO4)4
. 
5 H2O  
triclinic P1                 98.
Amorphous  calcium     
phosphate  (ACP)                                            
1.20-
2 . 2 0                
CaxHy(PO4)z
.
 nH2O
N=3-4,5;14-20%H2O
α - t r i c a l c i u m -                                                                                                
p h o s p h a t e   ( α - T C P )                                                                                                  
1.50  α-Ca3(PO4)2   monoclinic 
P21/a 
28.5
Β-tricalcium-                                      
p h o s p h a t e   ( β - T C P )                                                                                                 
1 . 5 0                            β-Ca3(PO4)2                                             rombohedral   
R3Ch   
2 9 . 6                                                                                    
Hydroxylapatite 
(HAP)                                                                                                                   
1 . 6 7                         Ca10(PO4)6(OH)2              monoclinic P21/b,       
or hexagonal  P63/ m                                      
117
Fluoroapatite (FAP)               1 . 6 7                           Ca10(PO4)6F2 hexagonal P63/m        122.3
   *K-Solubility product
Fig. 1.
Diffractogram of the experimental jow bone sample E1.
H-hydroxylapatite: Ca10(PO4)6(OH)2; M-monetite:CaHPO4; 
B-brushite:CaHPO4
. 2H2O   
Fig. 2.
 Diffractogram of the experimental jow bone sample E2.
H-hydroxylapatite: Ca10(PO4)6(OH)2;  M-monetite:CaHPO4;  111 S. D. Poštić / International Journal of BioMedicine 4(2) (2014) 109-113
corresponding crystal forms using data from JCPDS-ICDD 
[29] 72-0713 for brushite, 09-0077 for brushite, syn, 75-1520 
for monetite, 70-1425 for monetite, (synthesized), 74-0566 for 
hydroxylapatite, 76-0694 for hydroxyapatite, syn,  and data 
from JCPDS [29] (01-074-0565 for hydroxyapatite, 01-072-
0713 for brushite, 01-070-0359 for monetite, syn).
In  all  samples  hydroxylapatite  (bands  marked  H)  is 
present. In the sample E1 monetite  (M) and brushite  (B) are 
present simultaneously with hydroxylapatite. In the sample E2 
monetite is present too. The hydroxylapatite Ca10(PO4)6(OH)2 
was the dominant phase in samples C1 and C2, since bands of 
other kinds are not present, or their concentration is less than 
the detection limit. 
Discussion
Certain comprehensive studies have shown that natural 
HAp is non-stoichiometric (exhibits a Ca/P ratio higher than 
1.67) nanostructured crystals with carbonate groups and traces 
of different ions such as HPO2
−4 Na+, Mg2+, Sr2+, K+, Cl− and F− 
built into its structure [30,31], a finding that was not completely 
confirmed in the analysis in the present study. Additionally, 
the general formula of HAp is Ca14Ca26(PO4)6(OH)2, where 
Ca1 and Ca2 are two different crystallographic positions for 
10  calcium  atoms.  Four  calcium  atoms  are  situated  in  the 
Ca1 position, and they are surrounded by nine oxygen atoms, 
which belong to the PO4 tetrahedra. Six other calcium atoms, 
which are coordinated by the six O atoms of the PO4 tetrahedra 
and by one of the OH− ions, are placed in the Ca2 site [32-37]. 
This statement could be also discussed with the results of the 
present study in which hydroxylapatite was basically assigned 
as the Ca10(PO4)6(OH)2 structure. According to the literature 
data, the bone mineral apatite is generally considered to be the 
B-type and mixed AB-type [37-39] with an increase of A-type 
substituted for apatite in the old bone; hence, B-type HAp is 
the most abundant apatite in bones of young humans [40].
Data obtained in this study are in agreement with 
knowledge that osteoporosis is the process of formation of 
some other crystal forms of calcium phosphate, at least one, 
monetite, from HAp.
     Carbonate is the most abundant substitution in bone 
mineral  with  2.3–8  wt.%,  and  it  has  been  shown  to  vary 
depending  on  the  age  of  the  individual  [40,41].  This  was 
confirmed in this study as well.
Consequently,  hydroxylapatite  replaced  by  brushite 
or  monetite  reduces  bone  density  and  hardness,  since  the 
density and hardness of monetite (2.93 g/cm3; 3 Mohs) [42] 
and brushite (2.32 g/cm3; 21/2 Mohs) [43] are less than that of 
hydroxylapatite (3.16 g/cm3; 5 Mohs) [44]. 
Table 3 provides some characteristics of hydroxyapatite 
in  the  bone,  which  is  the  dominant  phase  in  samples  1–3 
(minimal  dislocation  density  (A),  microstrain  (B)  and 
crystallite radius (D)), calculated from data presented in Table 
2, according to the literature [45,46]. The changes of cited 
values are highest in sample 1, i.e., in the sample with two 
phases formed through osteoporotic processes.
The change of the crystallographic structure, formation 
from monetite and brushite by the recrystallization of the 
hydroxylapatite,  also  changes  the  relationship  of  Ca:P, 
according to data in Table 1, i.e., the amount of Ca in the 
osteoporotic bone must be less than in the normal bone. On 
the basis of these data, it is concluded that the reduction of 
calcium content in the solution, or physiologic environment, 
could influence transitions of hydroxylapatite to monetite or 
to brushite. Also, the formation of Ca++ stable complexes with 
other inorganic or organic compounds due to the change of 
physiological media can also be the cause of the transformation 
of the hydroxylapatite into the cited crystal forms.
Fig. 3. 
Diffractogram of the control jaw bone sample C1. 
   H-hydroxyapatite: Ca10(PO4)6(OH)2   
Table 2. 
The 2θ value of the diffraction peaks (deg), relative intensity (i/s), d- spacing  (A), (Miller  index (h k l) and phase F (H-hydroxylapatite, 
B-brushite, M-monetite) for samples 1, 2 and 3.   
Sample 1 Sample 2 Sample 3
2θ i/s D h k l F 2θ i/s D h k l F 2θ i/s D h k l F
21.00     250 4.230 1 2 -1 M 25.00 350 3.565 0 0 2 H 26.00 350 3.422 0 0 2 H
26.00 250 3.420 0 0 2 H 25.70 460 3.468 1 1 1  M 29.00 300 3.080 2 1 0 H
27.00 220 3.304 1 2 0 B 28.00 300 3.182 2 1 0 H 30.50 650 2.928 2 1 1 H
29.00 300 3.080 1 4 -1 M 28.70 370 3.100 0 -2 1 M 32.50 450 2.750 1 1 2 H
30.00 300 2.664 -1 2 1 B 31.00 680 2.884 2 1 1  H 34.00 220 2.637 2 0 2 H
31.00 550 2.884 2 1 1  H 32.00 410 2.790 3 0 0 H 40.00 200 2.251 1 3 0 H
33.00 400 2.711 3 0 0 H 33.00 300 2.711 1 1 2 H 46.00 200 1.969 4 0 1 H
34.00 250 2.750 2 0 1 M 39.00 200 2.305 1 3 0 H 50.50 190 1.808 3 2 1 H
34.50 200 2.637 2 0 2 H 46.50 200 1.949 2 2 2 H 53.00 185 1.726 0 0 4 H
40.00 200 2.251 1 3 0 H 49.00 190 1.892 1 3 3 H
48.00 180 1.892 1 3 2 H 54.00 180 1.696 0 0 4 H
53.00 150 1.737 3 0 3 H112                                               S. D. Poštić  / International Journal of BioMedicine 4(2) (2014) 109-113
The results of this work provide a particular set of data 
that specify characteristic diffraction peaks and phases in 
experimental atrophic and osteoporotic bones of cadavers in 
contrast to data obtained for regular structure of the control 
JBs of separate cadavers.
Conclusion
On  the  basis  of  X-ray  analysis,  forms  of  calcium 
phosphate, monetite and brushite, as well as hydroxylapatite, 
were established in osteoporotic samples, whereas only the 
hydroxylapatite compound was present in the normal bone 
sample. This result is the consequence of the basic chemical 
characteristics of the samples.
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